But for multi-millionaire Bryan Johnson, it's about investing $2 million dollars (about £1.6m) a year, and this included a ...

The Company is also developing a next-generation, non-surgical transcatheter based replacement venous valve called enVVe, which could appeal to an even larger market in terms of both patients and ...